DRC reports ‘significant drop’ in sleeping sickness over past decade
news desk Laugh
The Democratic Republic of the Congo (DRC) has announced that it has seen a significant decrease in human African trypanosomiasis (HAT), also known as sleeping sickness today.
” … This government commitment had such promising effects as reducing cases from 2012 to 2022 from 6,000 to 510 cases. The celebration of this day aims to raise awareness among the stakeholders involved in the struggle and the international community of the sustainability of the activities, support and ownership of this struggle with the aim of preserving the collective memory about the achievements achieved through this commitment on the one hand and on the other hand, of the devastating health, social and economic consequences in the development families and communities. said the Minister of Public Health, Hygiene and Prevention, Dr. Jean-Jacques Mbongani.
He stressed that we must continue the path to achieve success, saying: “Certainly, the results and progress are amazing, but the will to eradicate this endemic disease remains the goal.”
While the representative of the World Health Organization in the Democratic Republic of the Congo welcomed the efforts made by the Congolese state in cooperation with its technical and financial partners as well as donors, he affirmed his organization’s support for that ambition to eradicate sleeping sickness in the Democratic Republic of the Congo. By 2030 to be achieved as soon as possible.
Acoziborole, a new single-dose oral drug, is emerging as a great therapeutic advance. Clinical trials of this molecule have had a 95% success rate.
” So we are fortunate to believe that this new single-dose oral treatment will pave the way for stopping transmission of the disease in the days that follow (…). We are on the cusp of eliminating sleeping sickness. On this day when our attention is focused on neglected diseases, we must allocate more financial resources in the fight against HAT to allow the Congolese people to enjoy a more peaceful life. said Chirac Bolanga Melemba, DNDi’s Regional Director.
Bill & Melinda Gates Foundation delegate Rachel Bronzan expressed the importance of watching the pills to avoid any relaxation.
” This treatment will be available in the near future. The battle was long and difficult. Significant progress was followed by a devastating re-emergence of disease when the battle ceased. So the struggle must continue She said.
In recent years, sleeping sickness has been treated with Fexinidazole, the first fully oral medication approved to treat both stages of this condition.
The Democratic Republic of the Congo is the country most affected by this disease in the world with 70% of reported cases.
African sleeping sickness: Togo eliminates it as a public health problem
African sleeping sickness: a short Q&A with an ID doctor
Study: New sleeping sickness drug could be key to eliminating disease transmission by 2030